RECRUITING

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Talk to us

Conditions

Autism Spectrum DisorderTranscranial Magnetic Stimulation

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).

Official Title

Noninvasive Brain Stimulation to Treat Core Social Deficits in Autism Spectrum Disorder

Quick Facts

Study Start:2022-03-17
Study Completion:2025-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04936009

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Individuals between the ages of 18 and 40 years old with typical development or with a diagnosis of autism spectrum disorder.
  2. * Individuals able to participate in an EEG and eye-tracking experiment.
  1. * Participants reporting significant head trauma or serious brain illness.
  2. * Participants with major psychiatric illness that would preclude completion of study measures.
  3. * Participants with a history of serious medical illness, stroke, seizures, epileptiform EEG abnormalities, or family history of seizures.
  4. * Participants taking prescription medications that may affect cognitive processes under study.
  5. * Participants who have taken alcohol or recreational drugs within the preceding 24 hours.
  6. * Females of known/suspected pregnancy or who test positive on a pregnancy test.
  7. * Participants with a history of metalworking or injury by shrapnel or metallic objects are also excluded.
  8. * Participants with a history of prior TMS therapy or use of an investigational drug within 12 weeks of visit.
  9. * Participants with an IQ (intelligence quotient) below 80.

Contacts and Locations

Study Contact

Nicole Wright, BS
CONTACT
203-785-3488
n.wright@yale.edu
Adam Naples, PhD
CONTACT
203-785-2583
adam.naples@yale.edu

Principal Investigator

James McPartland, PhD
PRINCIPAL_INVESTIGATOR
Yale University

Study Locations (Sites)

Yale University Child Study Center
New Haven, Connecticut, 06520
United States

Collaborators and Investigators

Sponsor: Yale University

  • James McPartland, PhD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-17
Study Completion Date2025-07-01

Study Record Updates

Study Start Date2022-03-17
Study Completion Date2025-07-01

Terms related to this study

Keywords Provided by Researchers

  • Transcranial Magnetic Stimulation

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder